Upcoming Virtual Conference: 34th Annual HIV/AIDS on the Front Line (September 22, 2021)Posted September 10, 2021
The purpose of this activity is to provide healthcare professionals the opportunity to enhance their knowledge with new and updated data to improve HIV/AIDS treatment for people living with HIV, enrich compassionate caring skills, and provide information that will support the diagnosis, treatment, and prevention of HIV. The sessions will be presented by practicing experts and based upon the latest state-of-the-art research of HIV therapy and care. The activity will explore cultural and societal issues that directly impact HIV care and prevention. At the end of this activity, it is expected that the participants will have an up-to-date understanding of the best clinical approaches for HIV treatment and prevention.
This activity was developed for MDs, RNs, ID Specialists, PAs, NPs, Psychiatrists, MFTs, LCSWs, Pharmacists, Substance Abuse Professionals, Case Managers, Pediatric ID Specialists and the General Public.
At the conclusion of this activity, the participants will be able to:
- Identify newly approved antiviral therapies and future therapies that will improve outcomes for individuals with HIV.
- Identify newer treatments protocols recommended for the treatment of STI’s.
- Discuss how mental health issues, substance use, and COVID-19 impact the care of patients living with HIV.
The University of California, Irvine School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of California, Irvine School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.A non-physician Healthcare Professional certificate of attendance for CEU purposes will be provided upon request. Non-physicians may submit the HP certificate to their own credentialing board (nursing, pharmacy, social work, etc.) to see if they can obtain transferrable CEU’s.
GENERAL DISCLOSURE STATEMENT
It is the policy of the University of California, Irvine School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all educational activities. The views and opinions expressed in this activity are those of the speakers and do not necessarily reflect the views of the University of California, Irvine School of Medicine. Full disclosure will be included during the conference presentation and listed on the conference website (www.hivconference.org).
In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your needs. For any special requests, please call (714) 456-6871.
CALIFORNIA ASSEMBLY BILL 1195
This activity is in compliance with California Assembly Bill 1195, which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. For specific information regarding Bill 1195 and cultural and linguistic competency, please visit the CME website at http://www.meded.uci.edu/CME/.
Welcome and Introductions
Geeta Gupta, MD
Pacific AIDS Education & Training Center – Orange County & Inland Empire
University of California, Irvine
HIV & PrEP Update
Eric S. Daar, MD
Chief of HIV Medicine, Division of Infectious Diseases, Harbor-UCLA Medical Center
Investigator, Lundquist Institute
Professor of Medicine, David Geffen School of Medicine at UCLA
Kathleen Jacobson, MD
Co-Chair California COVID- 19 Testing Task Force
Chief of STD Control Branch
California Department of Public Health
11:00 A.M. BREAK
Structural Racism & Health Disparities in HIV
Aunsha Hall-Everett, MA
California Prevention Training Center
Mental Health & Substance Abuse Challenges
Lawrence McGlynn, MD
Clinical Professor, Psychiatry and Behavioral Sciences
Stanford Hospital and Clinics
This program is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $3,278,366. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.
Subscribe to receive new resources in your inboxSubscribe